HealthcareInsights101’s Post

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/djefh_59 The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity, Tecan Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience #hts #drugdiscovery #biotechnology #pharmainnovation #lifesciences

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dxtRJrNe The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity, Tecan Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BRAND GMBH + CO KG BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience #highthroughputscreening #drugdiscovery #hts #screeningtechnology #biotechnology

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dtphnyZW The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity, Tecan Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BRAND GMBH + CO KG BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience #highthroughputscreening #drugdiscovery #hts #screeningtechnology #biotechnology

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dnn6jtvM The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity. TECAN GROUP AG-REG Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson Brand Trust GmbH BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat USA Axxam Sygnature Discovery Crown Bioscience #highthroughputscreening #drugdiscovery #biotechnology #htstechnology #pharmaresearch

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dJ8cr6Ev The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity. TECAN GROUP AG-REG Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson Brand Trust GmbH BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat USA Axxam Sygnature Discovery Crown Bioscience #highthroughputscreening #drugdiscovery #biotechnology #htstechnology #pharmaresearch

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure :-https://lnkd.in/dGUubQZs The global high throughput screening market in terms of revenue was estimated to be worth $25.7 billion in 2023 and is poised to reach $44.5 billion by 2028, growing at a CAGR of 11.6% from 2023 to 2028. The companies that are operating in this market globally Thermo Fisher Scientific Agilent Technologies, Merck KGaA, Darmstadt, Germany Danaher Corporation Revvity, Tecan Group AG Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BRAND GMBH + CO KG BMG LABTECH DIANA Biotechnologies, Creative Biolabs HighRes Biosolutions Biomat USA Axxam Sygnature Discovery Crown Bioscience. #highthroughputscreening #hts #drugdiscovery #biotechnology #pharmaceuticalresearch

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dwhPYC8T The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck KGaA, Darmstadt, Germany Danaher Corporation Revvity TECAN GROUP AG-REG Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience . #highthroughputscreening #drugdiscovery #biotech #hts #pharmatech

Attention #PMRC attendees! Connect with Danny Farkas this week to learn more about the role that incentives plays in the Pharma Market Research space and how Virtual Incentives helps ease the burden of issuing rewards for healthcare research participants globally! #pharma #conference #marketresearch #global #incentives #rewards

𝐒𝐢𝐧𝐠𝐥𝐞-𝐔𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐰𝐨𝐫𝐭𝐡 $9.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐰𝐢𝐭𝐡 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 15.4% Download PDF Brochure @ https://lnkd.in/gtE8Fjjs The 𝐬𝐢𝐧𝐠𝐥𝐞-𝐮𝐬𝐞 𝐛𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐨 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐟𝐫𝐨𝐦 $4.4 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐭𝐨 $9.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐝𝐫𝐢𝐯𝐞𝐧 𝐛𝐲 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 15.4%. The market is driven by the adoption of single-use technologies among 𝐂𝐃𝐌𝐎𝐬, 𝐂𝐌𝐎𝐬, 𝐚𝐧𝐝 𝐒𝐌𝐄𝐬, as well as the advantages of these systems over traditional stainless-steel bioreactors, including reduced capital investment and lower resource consumption. #Opportunities lie in the development of hybrid facilities combining single-use and stainless-steel systems. #NorthAmerica currently leads the market, with major players including Sartorius AG Microsites Start A Misson, Danaher Corporation, and Thermo Fisher Scientific Inc. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: LOTTE BIOLOGICS      Erbi Biosystems, a part of MilliporeSigma      OmniBRx Biotechnologies Pvt Ltd      Zencore Biologics  

India has emerged as a biomanufacturing hub and has proved the competencies during COVID 19 by supplying vaccines to the globe. Join me in a panel discussion to uncover the future potential of innovation, collaboration and outsourcing... #BIO2024 #Biosimilars #biotech #Pharmaceutical Manufacturing